Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 08/H0805/56 | Other Identifier | National Research Ethics Service |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| St Thomas' Hospital, London | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine the bone mineral density in male and female patients with HIV infection according to age groups.
This will enable a practical approach to screening for osteoporosis and the management and prevention of fragility fractures in people with HIV.
In addition, all risk factors commonly associated with fragility fractures and osteoporosis are collected, as is HIV drug history.
Hence, as secondary outcomes, the associations with reduced bone mineral density can be ascertained.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Controls, females | Controls who are presumed HIV uninfected, females, aged 18 or above | ||
| Controls, males | Controls presumed HIV uninfected, males, aged 18 or above | ||
| HIV infected patients, males | HIV patients, males, aged 18 or above | ||
| HIV patients, | HIV patients, females, aged 18 or above |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Bone mineral density at Hip | Bone mineral density as determined by DXA scanning | The outcome is measured within 6 months (0-6 months) after entry to the study. |
| Measure | Description | Time Frame |
|---|---|---|
| Bone mineral density at spine (L4) | As determined by DXA scan | The outcome is measured within 6 months (0-6 months) after entry to the study. |
| Any lifetime fractures reported by subjects | Self-reported fractures of any type |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
A randomly recruited numbers of HIV uninfected controls and HIV patients aged 18 years or above, equally matched for age, and gender.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Barry S Peters, MD PhD | King's College London | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| St Thomas, Hospital | London | SE30AA | United Kingdom |
Not provided
| ID | Term |
|---|---|
| D010024 | Osteoporosis |
| D050723 | Fractures, Bone |
| D015658 | HIV Infections |
| ID | Term |
|---|---|
| D001851 | Bone Diseases, Metabolic |
| D001847 | Bone Diseases |
| D009140 | Musculoskeletal Diseases |
| D008659 | Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Plasma and urine
| At any stage during persons life up to and including the last visit for the volunteer to the study. |
| Vitamin D levels | Plasma vitamin D | The outcome is measured within 6 months (0-6 months) after entry to the study. |
| D009750 |
| Nutritional and Metabolic Diseases |
| D014947 | Wounds and Injuries |
| D000086982 | Blood-Borne Infections |
| D003141 | Communicable Diseases |
| D007239 | Infections |
| D015229 | Sexually Transmitted Diseases, Viral |
| D012749 | Sexually Transmitted Diseases |
| D016180 | Lentivirus Infections |
| D012192 | Retroviridae Infections |
| D012327 | RNA Virus Infections |
| D014777 | Virus Diseases |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D007153 | Immunologic Deficiency Syndromes |
| D007154 | Immune System Diseases |